期刊文献+

沉默高迁移族蛋白B1基因抑制胃癌MGC-803细胞的侵袭转移 被引量:8

Inhibitory effect of silencing of HMGB1 gene expression on the invasive and metastatic abilities ofMGC-803 gastric cancer cells
原文传递
导出
摘要 目的探讨小分子干扰RNA(siRNA)抑制高迁移族蛋白B1(HMGBl)基因表达对胃癌细胞株MGC-803侵袭转移能力的影响及其作用机制。方法设计、合成靶向HMGBl基因的siRNA,以脂质体为载体转染胃癌细胞株MGC-803。Transwell小室模型和划痕实验测定细胞侵袭及迁移能力,四甲基偶氮唑蓝比色法检测细胞对Matrigel基质胶的黏附能力,电泳迁移实验检测化学合成核因子KB(NF—KB)的活性,逆转录聚合酶链反应和Westernblot方法检测HMGBl、基质金属蛋白酶9(MMP-9)mRNA和蛋白的表达。结果HMGBlsiRNA可明显抑制MGC-803胃癌细胞株HMGBImRNA和蛋白的表达。HMGBlsiRNA转染组细胞侵袭穿膜细胞的数量为(142.7±3.4)个/视野,与未转染组[(303.5±4.3)个/视野]比较,差异有统计学意义(P〈0.05)。HMGBlsiRNA转染组细胞迁移穿膜细胞的数量为(293.7±4.4)个/视野,与未转染组[(445.5±5.6)个/视野]比较,差异有统计学意义(P〈0.05)。HMGBlsiRNA转染组的细胞黏附率为(33.4±0.03)%,与未转染组[(57.4±4.2)%]比较,差异有统计学意义(P〈0.05)。HMGBlsiRNA转染组MGC-803细胞MMP-9mRNA的相对表达水平(0.2±0.1)低于未转染组(1.4±0.4,P〈0.05)。HMGBlsiRNA转染组细胞MMP-9蛋白的相对表达水平(0.4±0.1)低于未转染组(2.34±0.7,P〈0.05)。HMGBlsiRNA转染组NF.KB活性明显低于未转染组。结论HMGBl基因沉默可有效抑制MGC-803细胞的侵袭转移,其机制可能与调控NF-KB的活性和MMP-9表达有关。 Objective To investigate the effect of high mobility group box-1 (high mobility group box B 1, HMGB1 ) on the invasive and metastatic abilities of gastric cancer cell line MGC-803 and analyze the possible mechanisms. Methods HMGB1 gene targeting siRNA was designed and synthesized, and HMGBI siRNA oligonucleotides were transfected into the MGC-803 cells with Lipofectamine 2000. The invasive and migratory abilities were detected by transwell assay and scratch assay. The Matrigel matrix glue adhesive ability of MGC-803 cells was evaluated by MTF assay. NF-KB activity was detected by electrophoretic mobility shift assay. The mRNA and protein levels of HMGB1 and MMP-9 were determined by RT-PCR and Western blot, respectively. Results The siRNA down-regulated the levels of HMGB1 mRNA and protein. Compared with that of the control group, the number of invasive ( 142.7 ± 3.4 /view vs. 303.5 ±4.3/view ) and migratory ( 293.7 ± 4.4/view vs. 445.5 ± 5.6/view) cells was significantly increased (P 〈 0. 05) and the adhesive ability of MGC-803 cells to Matrige] was significantly elevated (33.4 ± 0.03% vs. 57.4 ± 4.2% , P 〈 0.05 ). In addition, silencing of HMGB1 gene significantly inhibited the activity of NF-kB and the relative expression folds of mRNA ( 0.2 + 0. 1 vs. 1.4 ±0.4, P 〈 0.05 ) and protein (0.4±0.1 vs. 2.3±0.7, P〈0. O5)ofMMP-9. Conclusion Silencing of HMGB1 can effectively inhibit the invasion and migration of gastric cancer cells and this effect of HMGB1 may be partly due to itsregulation of NF-KB and MMP-9 expressions.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2013年第4期244-248,共5页 Chinese Journal of Oncology
基金 山东省自然科学基金(ZR2009CMl38)
关键词 胃肿瘤 肿瘤侵润 肿瘤转移 RNA干扰 高迁移率族蛋白1 Stomach neoplasms Neoplasm invasiveness Neoplasm metastasis RNAinterference High mobility group box-1
  • 相关文献

参考文献14

  • 1Ellerman JE, Bmw CK, de Vera M, et al. Masquerader: high nx, bility gup box-I and cancer. Clin Cancer Res, 2007, 13:2836-2848. 被引量:1
  • 2Kusume A, Sasahira T, Luo Y, et al. Suppression of dendritic cells by HMGBI is associated with lymph node metastasis of human colon cancer. PathobioIo, 2009, 76:155-162. 被引量:1
  • 3Sasahira T, Kirita T, Oue N, el al. High mohility group box-l- inducible melanoma inhibitory activity is assxiated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma. Cancer Sci, 2008, 99 : 1806-1812. 被引量:1
  • 4Takada M, Hirata K, Ajiki T, el al. Expression of receptr for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells, ltepatogastrnenterology, 2004, .51 : 928- 930. 被引量:1
  • 5Ishiguro H, Nakaigawa N, Miyoshi Y, et al. Receptor fi)r advanced glycation end prtMucts (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate, 2005, 64:92-100. 被引量:1
  • 6Chung HW, Lee SG, Kim H, et al. Serum high mobility group box-I (HMGBI) is closely associated with the clinical and pathologic features of gastric cancer. J Transl Med, 2009, 7:38. 被引量:1
  • 7Akaike H, Kono K, Sugai H, et al. Expression of high mobility grtup box chromosomal protein-1 (HMGB-I) in gastric cancer. Anticancer Res, 2007, 27:449-457. 被引量:1
  • 8Naglova It,Bucova M. HMGBI and its physiologicd and pathological roles. Bratisl l.ek Listy, 2012, 113:163-171. 被引量:1
  • 9Libra M, Scalisi A, Vella N, et al. Uterine cervical carcinoma: role of matrix metalloproteinases. Int J Oncol, 2009, 34:897-903. 被引量:1
  • 10Yang S, Zhao Z, Wu R, et al. Exprsion and biological relationship of va:ular endothelial growth factor-A and matrix metalloproteinase- 9 in gastric carcinoma. J lnt Med Res, 2011, 39:2076-2055. 被引量:1

同被引文献89

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部